Medinotec Inc. MDNC
OTC PK
| 08/31/2026 | 05/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 20.73% | 45.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.73% | 45.50% | |||
| Cost of Revenue | 22.13% | 38.84% | |||
| Gross Profit | 19.29% | 53.02% | |||
| SG&A Expenses | 19.66% | 6.11% | |||
| Depreciation & Amortization | 2.35% | -63.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.36% | 18.40% | |||
| Operating Income | 12.05% | 168.47% | |||
| Income Before Tax | -13.57% | 176.35% | |||
| Income Tax Expenses | 1,132.59% | 93.38% | |||
| Earnings from Continuing Operations | -81.58% | 420.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -81.58% | 420.35% | |||
| EBIT | 12.05% | 168.47% | |||
| EBITDA | 11.03% | 198.16% | |||
| EPS Basic | -81.48% | 373.91% | |||
| Normalized Basic EPS | -13.51% | 164.91% | |||
| EPS Diluted | -81.48% | 373.91% | |||
| Normalized Diluted EPS | -13.51% | 164.91% | |||
| Average Basic Shares Outstanding | 0.00% | 17.51% | |||
| Average Diluted Shares Outstanding | 0.00% | 17.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||